Predicting the CD34 content of mobilized peripheral blood leukapheresis products: Single institution experience over 20 years
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2024Yazar
Mutlu, Yaşa GülSevcik, Joan
Kiss, Joseph Elmer
Lister, John
Moore, Linda R.
Donnenberg, Albert D.
Üst veri
Tüm öğe kaydını gösterKünye
Mutlu, Y. G. Sevcik, J., Kiss, J. E., Lister, J., Moore, L. R. ve Donnenberg, A. D. (2024). Predicting the CD34 content of mobilized peripheral blood leukapheresis products: Single institution experience over 20 years. Cytotherapy, 26(2), 171-177. https://dx.doi.org/10.1016/j.jcyt.2023.09.005Özet
Background aims: Since the standardization of CD34 measurement by flow cytometry, predictors of leukapheresis CD34 yield have played a pivotal role in planning donor leukaphereses. We describe here a single institution's experience with a multivariate predictor that was used for 2,929 products without alteration for 20 years. Methods: The ordinary least squares regression model variables included log peripheral CD34 count, collection duration (3- versus 4 -hours), collection number, donor sex, and transplant type. Results: During the study period we changed flow cytometers twice and leukapheresis instruments once. During the Cobe Spectra era the predictor explained 90% of the variability in CD34 collection yield for autologous transplants (r(2) = 0.90), and 70% for allogeneic transplants with an overall sensitivity to predict a CD34 yield of >= 1 x 10(6)/kg of 97.7%, and specificity of 81.4%. Conclusions: Implemented prospectively with real-time result reporting, the model allowed us to predict CD34 yield with both 3- and 4 -hour collection scenarios. Given this guidance, 3 -hour collections were selected by the clinical team 25% of the time, saving patient leukapheresis time and resources. When faced with a prediction of <1 x 10(6) CD34/kg, the clinical team chose to defer collection 72% of the time. In instances where leukapheresis was performed despite a poor predicted outcome, 85% of patients collected on the Cobe Spectra, and 92% of patients collected on the Optia, failed to collect at least 1 x 10(6) CD34/kg. A revised model is tested retrospectively on Optia data, and suggestions for further improvements are discussed.
WoS Q Kategorisi
Q2Kaynak
CytotherapyCilt
26Sayı
2Koleksiyonlar
- Makale Koleksiyonu [3694]
- PubMed İndeksli Yayınlar Koleksiyonu [4109]
- WoS İndeksli Yayınlar Koleksiyonu [6510]